Andre Filipe Miranda, MD
Urology · Cherry Hill, NJNPI 1124549233
Payments from drug & device makers
Across 127 payments — averaging $61.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$3K
- Boston Scientific$2K
- Procept Biorobotics Corporation$554
- Axonics, Inc.$509
- Coloplast$496
- Medtronic$371
- plus $1K from 26 others
What the payments were for
- Travel & lodging$1,34517%
- Food & beverage$3,49445%
- Education$3,00038%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 1 | $3,000 |
| Boston Scientific | 19 | $1,769 |
| Procept Biorobotics Corporation | 5 | $554 |
| Axonics, Inc. | 17 | $509 |
| Coloplast | 31 | $496 |
| Medtronic | 5 | $371 |
| Teleflex LLC | 5 | $241 |
| Sumitomo Pharma America, Inc. | 12 | $223 |
| Myriad Genetic Laboratories, Inc. | 3 | $70 |
| Calyxo, Inc. | 2 | $59 |
| Urovant Sciences Inc | 3 | $53 |
| Endo Pharmaceuticals Inc. | 2 | $44 |
| Antares Pharma, Inc. | 1 | $44 |
| AVEO Pharmaceuticals, Inc. | 1 | $36 |
| Myovant Sciences Inc. | 2 | $32 |
| Blue Earth Diagnostics | 1 | $29 |
| Angiodynamics, Inc. | 2 | $27 |
| Endo USA, Inc. | 1 | $26 |
| Kowa Pharmaceuticals America, Inc. | 1 | $23 |
| Agiliti Surgical, Inc. | 1 | $22 |
| Merck | 1 | $22 |
| BD | 1 | $21 |
| Astellas Pharma US Inc | 1 | $20 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $20 |
| Telix Pharmaceuticals | 1 | $19 |
| Ambu Inc. | 1 | $17 |
| Olympus America Inc. | 1 | $17 |
| Bayer | 1 | $17 |
| Civco Medical Instruments | 1 | $15 |
| Laborie Medical Technologies Corp. | 1 | $15 |
| Photocure Inc | 1 | $15 |
| AbbVie | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$3,000
- SpaceOAR VUE System - 10mL$1,181
- AquaBeam Robotic System$440
- INTERSTIM$279
- GENERAL KIDNEY STONE DISEASE$153
- UroLift$110
How this compares
$7,840 in reported general payments places this provider in the 75th percentile of 401 urology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 146 | $93,577 |
| GemtesaVibegron | 51 | $37,228 |
| Mirabegron ErMirabegron | 13 | $6,066 |
| Tamsulosin Hcl | 348 | $3,038 |
| Solifenacin Succinate | 57 | $2,574 |
| Estradiol | 35 | $1,919 |
| Finasteride | 96 | $1,476 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 43 | $804 |
| Oxybutynin Chloride ErOxybutynin Chloride | 30 | $330 |
| Oxybutynin Chloride | 23 | $106 |
| Cephalexin | 15 | $78 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 14 | $73 |
| Ciprofloxacin Hcl | 16 | $69 |
| Oxycodone Hcl | 15 | $21 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $20 | $93,577146 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $223 | $37,22851 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 401 urology providers in New Jersey.
Other urology in Cherry Hill
- Gordon BrownCherry Hill$2.8M
- Samuel WeprinCherry Hill$46K
- Nitin YerramHackensack$1.6M
- Michael StifelmanHackensack$1.5M
- Thomas MuellerLinwood$1.2M
- David SussmanLinwood$833K
- Michael IngberDenville$607K
- Ravi MunverHackensack$529K
- Grannum SantBridgewater$487K
- Mutahar AhmedMaywood$464K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.